Laura Frutos

ORCID: 0000-0003-2128-9504
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Orthopedic Surgery and Rehabilitation
  • Lymphoma Diagnosis and Treatment
  • Infectious Disease Case Reports and Treatments
  • Treatment of Major Depression
  • Health disparities and outcomes
  • Head and Neck Cancer Studies
  • Alcoholism and Thiamine Deficiency
  • Tendon Structure and Treatment
  • Musculoskeletal Disorders and Rehabilitation
  • Hernia repair and management
  • Sarcoma Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Diverticular Disease and Complications
  • CAR-T cell therapy research
  • Bone fractures and treatments
  • Protein Degradation and Inhibitors
  • Lung Cancer Treatments and Mutations
  • Endometriosis Research and Treatment
  • Liver Disease Diagnosis and Treatment
  • Bone health and treatments
  • Shoulder Injury and Treatment
  • Vascular anomalies and interventions
  • Vascular Tumors and Angiosarcomas
  • Anorectal Disease Treatments and Outcomes

Hospital Universitario Virgen de la Arrixaca
2013-2024

Universidad Católica de Córdoba
2023

Hospital Privado
2018-2020

Hospital General Universitario Morales Meseguer
2016

The mandatory confinement caused by the COVID-19 pandemic has significantly affected older adult population. main objective of this study is to assess independence in basic activities daily living (BADL) and instrumental (IADDL) people over 65 years age during social, preventive, compulsory isolation due COVID-19, identifying quantifying personal that present difficulties their execution. Design: A cross-sectional study. Settings: Private’s health insurance Hospital, Córdoba, Argentina....

10.3390/ijerph20054177 article EN International Journal of Environmental Research and Public Health 2023-02-26

Multiple myeloma (MM) remains incurable, with poor outcomes in heavily pretreated patients. Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment; however, after such patients soft-tissue plasmacytomas and other bone lesions remain poorly understood. This study included 63 relapsed/refractory MM treated either the CARTBCMA-HCB-01 clinical trial (ARI0002h; academic B-cell maturation [BCMA]-targeted CAR therapy) or compassionate use. The aim was to evaluate impact...

10.1182/bloodadvances.2024014360 article EN cc-by-nc-nd Blood Advances 2024-11-27

Sm-153 EDTMP is an effective treatment of painful bone metastases from different neoplasms. However, there are few studies describing clinical experience with this therapeutic modality. The aim study was to evaluate the efficacy in a group patients skeletal and poor pain control conventional therapies.Sixty-four treated were retrospectively evaluated. Nine twice. most common primaries breast 28 cases (44%) prostate 27 (41%). Treatment assessed by visual analog scale, analgesic consumption,...

10.1097/01.rlu.0000238304.08812.c1 article EN Clinical Nuclear Medicine 2006-09-13

Objetivos: Determinar la viabilidad anatómica del aumento continente primer compartimento dorsal y comunicar experiencia clínica de esta nueva técnica comparada con liberación clásica.
 Materiales Métodos: Estudio anatómico 12 muñecas cadavéricas para comprobar el su relación rama sensitiva radial. clínico retrospectivo que incluyó a pacientes >18 años, sin cirugías previas, tenosinovitis De Quervain respuesta al tratamiento ortopédico, operados entre enero 2014 2019, un seguimiento...

10.15417/issn.1852-7434.2020.85.4s.1174 article ES cc-by-nc-sa Revista de la Asociación Argentina de Ortopedia y Traumatología 2020-11-18

10.48158/seed2022.p273 article 44 Congreso de la Sociedad Española de Endoscopia Digestiva Abstracts Publication 2022-09-01

10.48158/seed2022.p185 article ES 44 Congreso de la Sociedad Española de Endoscopia Digestiva Abstracts Publication 2022-09-01

Introduction: In the workout of Follicular non-Hodgkin Lymphoma (FL), bone marrow assessment by biopsy (BMB) is a key component International Prognostic Index-2 (FLIPI-2) and progression disease within 24 months frontline FL chemoimmunotherapy initiation (POD24) models. Nevertheless, in several recent studies, positron emission tomography combined with computed (PET/CT) identification BMI was shown to be predictive progression-free survival (PFS) overall (OS) Methods: To evaluate independent...

10.1002/hon.34_2880 article EN Hematological Oncology 2021-06-01
Coming Soon ...